CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus

Conditions:   Cerebrospinal Fluid Levels of Amyloid Beta 1-42, H-tau and Phospho-tau Proteins;   Cognitive Impairment and Its Evolution After Hydrocephalus Treatment;   Motor Impairment and Its Evolution After Hydrocephalus Treatment;   Ventricular Size and Its Evolution After Implantation of a Ventriculop eritoneal Shunt Intervention:   Diagnostic Test: Lumbar CSF protein marker determination Sponsor:   University of Valencia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials